Skip to main content
. 2021 Aug 16;4(4):609–615. doi: 10.1089/crispr.2021.0038

Table 5.

Views on Oversight of Gene Editing Research

  Who should be included in the decision-making process about the oversight of gene-editing research? (Select all that apply) Who is best positioned to oversee how gene editing research should be conducted? (Select one)
Industry representatives 35% 0%
International bodies (e.g., World Health Organization) 76% 15%
Lay people 48% 1%
National government offices (e.g., National Institutes of Health, Food and Drug Administration) 95% 48%
Patients and patient advocates 76% 1%
Religious officials 22% 0%
Scientists 96% 28%
University offices (e.g., Institutional Review Boards, Institutional Animal Care and Use Committees) 66% 6%
Other 6% 2%